Volltextsuche
Hinweis: Bitte geben Sie einen Suchbegriff ein, z.B. "BMW", um alle Analysen und News über BMW aufgelistet zu bekommen, die innerhalb der Site von AktienCheck vorhanden sind! Zusätzlich können Sie noch eine Zeitspanne auswählen.
Suchergebnisse: (50236 Ergebnisse gefunden) Es werden maximal 1000 Erge.
| Datum | Thema | |
|---|---|---|
| 23.04.26 | ASML Charts Ambitious Course Amid Leadership Reshuffle and Investor Scrutiny | |
| ASML Holding NV is navigating a period of significant transition, underscored by a robust financial performance and strategic shifts in its corporate governance. At its Annual General Meeting held on April 22, 2026, shareholders endorsed a slate of measures that solidify the company's financial strategy while welcoming new leadership, all against the backdrop of raised annual targets. [...] | ||
| 23.04.26 | D-Wave Quantum's AI-Led Rally Confronts a Volatile Fundamentals Test | |
| A surge of institutional buying and explosive options activity has propelled D-Wave Quantum Inc. shares to around $21, a remarkable performance that starkly contrasts with its latest financial results. The quantum computing specialist’s recent gains are fueled not by its own operations but by a sector-wide revaluation triggered by Nvidia’s latest foray into the technology. [...] | ||
| 23.04.26 | Allianz Navigates Asian Expansion and Shareholder Payouts Amid Insolvency Fears | |
| The Allianz share price, hovering just below €400, reflects a company balancing aggressive growth with shareholder returns against a backdrop of rising economic risks. Trading at €389.80 on Wednesday, the stock retreated 1.27% from a 52-week high of €394.80 hit just a day earlier, pausing after a ten percent gain over the prior month. [...] | ||
| 22.04.26 | Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing | |
| STAFFORD, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced that on April 16, 2026, the Company received notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, because it has not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, the Company is not currently in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission. [...] | ||
| 22.04.26 | The Trade Desk: Aktie springt 6,9% nach Vollero-Ernennung | |
| Schwaches Wachstum, ein massiver Kursverfall und eine regelrechte Flucht im Management belasten The Trade Desk. Nun steuert der Werbetechnologie-Konzern gegen. Ein prominenter Neuzugang im Verwaltungsrat soll die drängendsten Governance-Probleme lösen und die Vorgaben der Technologiebörse Nasdaq wieder erfüllen. [...] | ||
| 22.04.26 | Heidelberger Druck's Strategy Faces a Critical Showcase | |
| Shares of Heidelberger Druckmaschinen have been on a rollercoaster, swinging from a weekly gain exceeding 20 percent to a sharp pullback. The volatility underscores a company grappling with immediate profit pressures while steering a complex strategic transformation. The upcoming interpack trade fair in Düsseldorf, running from May 7 to 13, 2026, will serve as a crucial public test for its new direction. [...] | ||
| 22.04.26 | Ocugen's Survival Hinges on Funding as Gene Therapy Pipeline Advances | |
| The stark reality for Ocugen Inc. is captured in a single, jarring figure: its average analyst price target sits at $9.75, while its shares trade near €1.52. This chasm between Wall Street's valuation and the market's price underscores the biotech firm's precarious position, caught between a promising gene therapy pipeline and a dire financial warning. [...] | ||
| 22.04.26 | Airbus Confronts Dual Challenge of Production Paralysis and Strategic Expansion | |
| As Airbus prepares to release its first-quarter results, the European aerospace giant finds itself navigating a perfect storm. The company is grappling with its weakest quarterly delivery performance in over two decades while simultaneously accelerating a strategic acquisition spree in cybersecurity. [...] | ||
| 22.04.26 | Graphite One's Alaska Mine Project Faces a Crucible of Deadlines and Discontent | |
| The race to build a major U.S. graphite supply is hitting severe turbulence in Alaska. Graphite One Inc., a developer aiming to construct the Graphite Creek mine, is navigating a perfect storm of local opposition, stringent deadlines, and competitive pressure, with its stock already down nearly 32% year-to-date to $0.80. [...] | ||
| 22.04.26 | AMD's Supply Chain Becomes the Critical Battleground as AI Orders Swell | |
| The race to dominate artificial intelligence hardware is creating a unprecedented strain on production. Advanced Micro Devices Inc. finds itself at the center of this scramble, with its stock reaching record highs amid a flood of major customer commitments. The company's ability to manufacture enough chips now stands as the single greatest determinant of its future growth, overshadowing even its technological advances. [...] |
